Health and Healthcare

Merck : MRK

All Merck Articles

1067 Articles

Lee Jackson | Feb 5, 2015 at 10:00 AM EST

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the…

Chris Lange | Feb 4, 2015 at 9:40 AM EST

Loss of Hep C Drug Status Weighs on Merck Earnings

Merck reported largely in-line fourth-quarter financial results Wednesday before the U.S. markets opened.

Chris Lange | Feb 1, 2015 at 8:56 AM EST

The Top 10 Corporate Earnings for the Week Ahead

24/7 Wall St. has put together a preview of some of the larger companies reporting quarterly results in the coming…

Paul Ausick | Jan 18, 2015 at 8:20 AM EST

Merck Is Top DJIA Stock in 2015

Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year…

Jon C. Ogg | Jan 9, 2015 at 11:25 AM EST

The Bullish and Bearish Case for Pfizer in 2015

One key consideration for the year ahead is that the Pfizer of 2016 or 2017 is likely to be night…

Paul Ausick | Jan 8, 2015 at 11:35 AM EST

The Bullish and Bearish Case for Merck in 2015

One key consideration for the year ahead is Merck's acquisitions of Idenix and Cubist Pharmaceuticals to expand its product offerings

Jon C. Ogg | Jan 8, 2015 at 8:15 AM EST

The Bullish and Bearish Case for Johnson & Johnson in 2015

One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have…

Paul Ausick | Jan 7, 2015 at 4:01 PM EST

The 4 Stocks That Lifted the DJIA on Wednesday

thinkstockJanuary 7, 2015: Markets opened higher on Wednesday after ADP and TrimTab reports on unemployment came in a shade above…

Lee Jackson | Jan 6, 2015 at 8:45 AM EST

5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List

A new resort from UBS highlights the firm's first Equity Focus list for 2015. Here are five of the highest…

Jon C. Ogg | Jan 5, 2015 at 8:20 AM EST

Top Analyst Upgrades and Downgrades: Akamai, Carnival, Chevron, Pollo Loco, Ford, F5, Lululemon, Starbucks and More

Monday's top analyst upgrades, downgrades and initiations include Akamai Technologies, Carnival, Chevron, El Pollo Loco, Ford, F5 Networks, Lululemon Athletica…

Lee Jackson | Dec 29, 2014 at 10:05 AM EST

5 Top Pharmaceutical Stock Picks for 2015

In a new research report, the SunTrust Robinson Humphrey team highlights the top pharmaceutical stocks to buy for 2015.

Jon C. Ogg | Dec 23, 2014 at 11:25 AM EST

Great Dividends: Meet the Preliminary 2015 Dogs of the Dow

With investors loving dividends so much, 24/7 always tries to take a look at what the Dogs of the Dow…

Chris Lange | Dec 19, 2014 at 2:58 PM EST

Merrill Lynch’s Top Health Care Stock Picks for 2015

24/7 Wall St. has compiled a list health care stocks that Merrill Lynch expects to be top performers in 2015.

Paul Ausick | Dec 15, 2014 at 4:01 PM EST

The 4 Stocks That Weighed on Monday’s Market

thinkstockDecember 15, 2014: Markets opened higher on Monday following a strong report on industrial production that was later describe as…

Paul Ausick | Dec 9, 2014 at 4:01 PM EST

The 4 Stocks That Weighed on Tuesday’s Market

thinkstockDecember 9, 2014: Markets opened lower on Tuesday following a sharp decline overnight in the Shanghai Composite after China’s central…

1 … 43 44 45 46 47 … 72

Merck : MRK

All Merck Articles

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

Loss of Hep C Drug Status Weighs on Merck Earnings

The Top 10 Corporate Earnings for the Week Ahead

Merck Is Top DJIA Stock in 2015

The Bullish and Bearish Case for Pfizer in 2015

The Bullish and Bearish Case for Merck in 2015

The Bullish and Bearish Case for Johnson & Johnson in 2015

The 4 Stocks That Lifted the DJIA on Wednesday

5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List

Top Analyst Upgrades and Downgrades: Akamai, Carnival, Chevron, Pollo Loco, Ford, F5, Lululemon, Starbucks and More

5 Top Pharmaceutical Stock Picks for 2015

Great Dividends: Meet the Preliminary 2015 Dogs of the Dow

Merrill Lynch’s Top Health Care Stock Picks for 2015

The 4 Stocks That Weighed on Monday’s Market

The 4 Stocks That Weighed on Tuesday’s Market

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Merck : MRK

All Merck Articles

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

Loss of Hep C Drug Status Weighs on Merck Earnings

The Top 10 Corporate Earnings for the Week Ahead

Merck Is Top DJIA Stock in 2015

The Bullish and Bearish Case for Pfizer in 2015

The Bullish and Bearish Case for Merck in 2015

The Bullish and Bearish Case for Johnson & Johnson in 2015

The 4 Stocks That Lifted the DJIA on Wednesday

5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List

Top Analyst Upgrades and Downgrades: Akamai, Carnival, Chevron, Pollo Loco, Ford, F5, Lululemon, Starbucks and More

5 Top Pharmaceutical Stock Picks for 2015

Great Dividends: Meet the Preliminary 2015 Dogs of the Dow

Merrill Lynch’s Top Health Care Stock Picks for 2015

The 4 Stocks That Weighed on Monday’s Market

The 4 Stocks That Weighed on Tuesday’s Market

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

Featured Reads

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month